Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
DiaMedica Therapeutics Inc.
DMAC
$
9.17
-0.86%
Sun November 8th, 2020
05:54
Earnings
Analysis
DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q3 2020 Results - Earnings Call Transcript
Seeking Alpha
Fri November 6th, 2020
17:14
Earnings
Analysis
DiaMedica Therapeutics Inc. 2020 Q3 - Results - Earnings Call Presentation
Seeking Alpha
Wed August 12th, 2020
14:48
Earnings
Analysis
DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha
Wed July 8th, 2020
12:18
Analysis
Diamedica Therapeutics started at buy with $14 stock price target at Maxim Group
MarketWatch
